0.1(top 100%)
impact factor
244(top 50%)
papers
84(top 100%)
citations
4(top 100%)
h-index
0.1(top 100%)
extended IF
247
all documents
90
doc citations
7(top 100%)
g-index

Top Articles

#TitleJournalYearCitations
1Impetigo - diagnosis and treatmentDermatologie Pro Praxi201826
2Maintenance therapy of acneDermatologie Pro Praxi20167
3Trends in treating perioral dermatitisDermatologie Pro Praxi20164
4Current view on skin photoprotectionDermatologie Pro Praxi20164
5Current possibilities of treatment of atopic eczemaDermatologie Pro Praxi20163
6Treatment of hidradenitis suppurativaDermatologie Pro Praxi20173
7Assessment of atopic eczema severity with EASIDermatologie Pro Praxi20203
8News in the treatment with peroral isotretinoinDermatologie Pro Praxi20172
9Herpes zoster - clinical course, therapy and prophylaxisDermatologie Pro Praxi20172
10PDT and its possible use in dermatologyDermatologie Pro Praxi20172
11Alopecia - overview, causes and current treatment optionsDermatologie Pro Praxi20202
12Seborrhoeic dermatitis in infancyDermatologie Pro Praxi20211
13Guselkumab (Tremfya)Dermatologie Pro Praxi20201
14Seborrhoeic dermatitis, differential diagnosis and treatment in the practiceDermatologie Pro Praxi20161
15Gorlin-Goltz syndromeDermatologie Pro Praxi20161
16PhotodermatosesDermatologie Pro Praxi20161
17The first case of nitrofurantoin-induced toxic epidermal necrolysis?Dermatologie Pro Praxi20161
18New classification of venoactive drugsDermatologie Pro Praxi20161
19Hydroquinone and tretinoin - new substances for extemporaneous preparationDermatologie Pro Praxi20171
20Preparations intended for the care of the skin suffering from atopic dermatitisDermatologie Pro Praxi20171
21The status of emollients in the current treatment of atopic dermatitisDermatologie Pro Praxi20171
22Angiokeratoma and disorders associated with multiple lesionsDermatologie Pro Praxi20171
23Czech version of the questionnaire Wound-QoLDermatologie Pro Praxi20171
24The safety of secukinumab in treating psoriasisDermatologie Pro Praxi20171
25Current therapeutical options in primary cutaneous T-cell lymphomasDermatologie Pro Praxi20181
26DemodicosisDermatologie Pro Praxi20181
27Over-the-counter drugs against hair lossDermatologie Pro Praxi20181
28Topical therapy of acne vulgarisDermatologie Pro Praxi20181
29ErythrodermaDermatologie Pro Praxi20181
30Long-term omalizumab therapy in a patient with severe chronic spontaneous urticariaDermatologie Pro Praxi20181
31Treatment of moderate‑to‑severeDermatologie Pro Praxi20191
32Treatment pyoderma gangrenosum by topical tacrolimusDermatologie Pro Praxi20191
33Summary of current over‑the‑counterDermatologie Pro Praxi20191
34Treatment of psoriasisDermatologie Pro Praxi20201
35The role of dermocosmetics in acne treatmentDermatologie Pro Praxi20201
36Dry skin: possible causes and everyday care optionsDermatologie Pro Praxi20201
37Types of anesthesia in outpatient mini-invasive aesthetics surgical proceduresDermatologie Pro Praxi20201
38Overview of agents for regeneration of skin barrier functionDermatologie Pro Praxi20201
39Skin manifestations COVID-19Dermatologie Pro Praxi20221
40Microbiome and probiotics in the context of dermatologyDermatologie Pro Praxi20221
41Current Role of 5-fluorouracil in the Treatment of Actinic KeratosisDermatologie Pro Praxi20221
4214. konference Akné a obličejové dermatózyDermatologie Pro Praxi20210
43Isoprinosine: case reportsDermatologie Pro Praxi20210
44Current perspective on treating lymphoedemaDermatologie Pro Praxi20210
4514. konference Akné a obličejové dermatózyDermatologie Pro Praxi20210
46Side effects of acne treatment and their solutionsDermatologie Pro Praxi20210
47Delaying surgical procedure in patients with venous leg ulcer leads to treatment prolongationDermatologie Pro Praxi20210
48How to prevent acne fulminans sine fulminansDermatologie Pro Praxi20210
49Možnosti rehabilitace u pacientů po prodělaném onemocnění covid-19Dermatologie Pro Praxi20210
50Risankizumab in the treatment of erythrodermic form of psoriasis in patient with associated sclerodermiaDermatologie Pro Praxi20210